Find Thymidine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

0

JDMF

0

EU WC

0

KDMF

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Europe

0

Canada

0

Australia

0

South Africa

0

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 50-89-5, Deoxythymidine, 2'-deoxythymidine, Thymidin, 5-methyldeoxyuridine, Beta-thymidine
Molecular Formula
C10H14N2O5
Molecular Weight
242.23  g/mol
InChI Key
IQFYYKKMVGJFEH-XLPZGREQSA-N
FDA UNII
VC2W18DGKR

Thymidine
A nucleoside in which THYMINE is linked to DEOXYRIBOSE.
1 2D Structure

Thymidine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
2.1.2 InChI
InChI=1S/C10H14N2O5/c1-5-3-12(10(16)11-9(5)15)8-2-6(14)7(4-13)17-8/h3,6-8,13-14H,2,4H2,1H3,(H,11,15,16)/t6-,7+,8+/m0/s1
2.1.3 InChI Key
IQFYYKKMVGJFEH-XLPZGREQSA-N
2.1.4 Canonical SMILES
CC1=CN(C(=O)NC1=O)C2CC(C(O2)CO)O
2.1.5 Isomeric SMILES
CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)O
2.2 Other Identifiers
2.2.1 UNII
VC2W18DGKR
2.3 Synonyms
2.3.1 MeSH Synonyms

1. 2' Deoxythymidine

2. 2'-deoxythymidine

3. Deoxythymidine

2.3.2 Depositor-Supplied Synonyms

1. 50-89-5

2. Deoxythymidine

3. 2'-deoxythymidine

4. Thymidin

5. 5-methyldeoxyuridine

6. Beta-thymidine

7. Dthyd

8. Thymine-2-desoxyriboside

9. 5-methyldeoxyurindine

10. 5-methyl-2'-deoxyuridine

11. Deoxyribothymidine

12. Thymine-2-deoxyriboside

13. Thyminedeoxyriboside

14. Thymine Deoxyriboside

15. Dthd

16. 2'-thymidine

17. Uridine, 2'-deoxy-5-methyl-

18. Dt

19. Zidovudine Related Compound D

20. Doxribtimine

21. Thymine 2'-deoxyriboside

22. 2'-deoxy-5-methyluridine

23. Ai3-52267

24. Beta-d-ribofuranoside, Thymine-1 2-deoxy-

25. 157049-39-3

26. Nsc 21548

27. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione

28. Chebi:17748

29. Thymine 2-desoxyriboside

30. Vc2w18dgkr

31. 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione

32. 2,4(1h,3h)-pyrimidinedione, 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-methyl-

33. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione

34. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1h,3h)-dione

35. Nsc-21548

36. [3h]-thymidine

37. Ncgc00142484-03

38. Mfcd00006537

39. Alpha-tritiated Thymidine

40. 146183-25-7

41. 157049-40-6

42. Thm

43. 1-(2-deoxy-.beta.-d-ribofuranosyl)-5-methyluracil

44. 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1h,3h)-dione

45. 1-(2-deoxy-beta-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1h,3h)-dione (thymidine)

46. 1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydro-furan-2-yl)-5-methylpyrimidine-2,4(1h,3h)-dione

47. Ccris 1283

48. Einecs 200-070-4

49. Unii-vc2w18dgkr

50. Deoxyribosylthymine

51. 4qsv

52. Thymidinedeoxyriboside

53. 1w2g

54. Thymidine, >=99%

55. Bdbm1

56. Thymidine [mi]

57. Thymidine [inci]

58. Thymidine (8ci,9ci)

59. Dsstox_cid_3661

60. Doxribtimine [inn]

61. Bmse000244

62. Epitope Id:138113

63. Thymidine [mart.]

64. Ec 200-070-4

65. Thymidine [who-dd]

66. Thymidine [who-ip]

67. 2'-deoxy-5-methyl-uridine

68. Dsstox_rid_77133

69. Dsstox_gsid_23661

70. Schembl19894

71. 50-88-4

72. 2'-dt

73. Chembl52609

74. Gtpl4718

75. Dtxsid5023661

76. Zidovudine Related Compound D Rs

77. Zinc25672

78. Act03217

79. Hy-n1150

80. Str05630

81. Thymidine, >=99.0% (hplc)

82. Tox21_111560

83. Hg1139

84. S4803

85. Akos015895360

86. Stavudine Impurity C [who-ip]

87. Thymine-1 2-deoxy-b-d-ribofuranoside

88. Ac-1475

89. Am83949

90. Ccg-266886

91. Cs-w019644

92. Db04485

93. Cas-50-89-5

94. Deoxythymidine; 2'-deoxythymidine

95. Ncgc00142484-01

96. 1-[(4s,2r,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,3-dihydropyri Midine-2,4-dione

97. Stavudine Impurity C [ep Impurity]

98. Thymidine, Vetec(tm) Reagent Grade, 99%

99. Db-030432

100. Zidovudine Impurity E [ep Impurity]

101. T0233

102. Thymine-1 2-deoxy-beta-delta-ribofuranoside

103. 1-(2-deoxy-a-d-ribofuranosyl)-5-methyluracil

104. 1-(2-deoxy-beta-ribofuranosyl)-5-methyluracil

105. C00214

106. Zidovudine Related Compound D [usp-rs]

107. A828337

108. Q422464

109. Sr-01000883981

110. (1-[2-deoxy-beta-d-ribofuranosyl]-5-methyluracil)

111. J-700251

112. Sr-01000883981-1

113. Zidovudine Related Compound D [usp Impurity]

114. Brd-k28309349-001-02-4

115. Q27124084

116. D7e43a69-265b-4daa-bc8f-193fb357140f

117. Thymidine, Powder, Bioreagent, Suitable For Cell Culture

118. 1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione

119. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1h,3h)-dione

120. 1-(2-deoxy-b-d-erythro-pentofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione

121. 1-(2-deoxy-beta-delta-erythro-pentofuranosyl)-5-methyl-2,4(1h,3h)-pyrimidinedione

122. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione

123. Zidovudine Related Compound D, United States Pharmacopeia (usp) Reference Standard

124. 1-(2-deoxy-.beta.-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1h,3h)-dione [who-ip]

125. 1-(2-deoxy-beta-d-ribofuranosyl)-5-methyluracil; 1-(2-deoxy-beta-d-ribofuranosyl)thymine; Thymine Deoxyriboside; 2'-deoxythymidine; 5-methyldeoxyuridine

126. 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione

127. 1211376-53-2

2.4 Create Date
2004-09-16
3 Chemical and Physical Properties
Molecular Weight 242.23 g/mol
Molecular Formula C10H14N2O5
XLogP3-1.2
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass242.09027155 g/mol
Monoisotopic Mass242.09027155 g/mol
Topological Polar Surface Area99.1 Ų
Heavy Atom Count17
Formal Charge0
Complexity381
Isotope Atom Count0
Defined Atom Stereocenter Count3
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 50-89-5 / Thymidine API manufacturers, exporters & distributors?

Thymidine manufacturers, exporters & distributors 1

36

PharmaCompass offers a list of Thymidine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Thymidine manufacturer or Thymidine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thymidine manufacturer or Thymidine supplier.

API | Excipient name

Thymidine

Synonyms

50-89-5, Deoxythymidine, 2'-deoxythymidine, Thymidin, 5-methyldeoxyuridine, Beta-thymidine

Cas Number

50-89-5

Unique Ingredient Identifier (UNII)

VC2W18DGKR

About Thymidine

A nucleoside in which THYMINE is linked to DEOXYRIBOSE.

DSSTox_CID_3661 Manufacturers

A DSSTox_CID_3661 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3661, including repackagers and relabelers. The FDA regulates DSSTox_CID_3661 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3661 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of DSSTox_CID_3661 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.

DSSTox_CID_3661 Suppliers

A DSSTox_CID_3661 supplier is an individual or a company that provides DSSTox_CID_3661 active pharmaceutical ingredient (API) or DSSTox_CID_3661 finished formulations upon request. The DSSTox_CID_3661 suppliers may include DSSTox_CID_3661 API manufacturers, exporters, distributors and traders.

click here to find a list of DSSTox_CID_3661 suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.

DSSTox_CID_3661 USDMF

A DSSTox_CID_3661 DMF (Drug Master File) is a document detailing the whole manufacturing process of DSSTox_CID_3661 active pharmaceutical ingredient (API) in detail. Different forms of DSSTox_CID_3661 DMFs exist exist since differing nations have different regulations, such as DSSTox_CID_3661 USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A DSSTox_CID_3661 DMF submitted to regulatory agencies in the US is known as a USDMF. DSSTox_CID_3661 USDMF includes data on DSSTox_CID_3661's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The DSSTox_CID_3661 USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of DSSTox_CID_3661 suppliers with USDMF on PharmaCompass.

DSSTox_CID_3661 NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing DSSTox_CID_3661 as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for DSSTox_CID_3661 API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture DSSTox_CID_3661 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain DSSTox_CID_3661 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a DSSTox_CID_3661 NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of DSSTox_CID_3661 suppliers with NDC on PharmaCompass.

DSSTox_CID_3661 GMP

DSSTox_CID_3661 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of DSSTox_CID_3661 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right DSSTox_CID_3661 GMP manufacturer or DSSTox_CID_3661 GMP API supplier for your needs.

DSSTox_CID_3661 CoA

A DSSTox_CID_3661 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_3661's compliance with DSSTox_CID_3661 specifications and serves as a tool for batch-level quality control.

DSSTox_CID_3661 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_3661 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

DSSTox_CID_3661 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_3661 EP), DSSTox_CID_3661 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_3661 USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty